Benjamin Edwards’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$246K Sell
103,695
-4,020
-4% -$5.68K ﹤0.01% 1333
2026
Q2
$181K Sell
107,715
-7,834
-7% -$11.4K ﹤0.01% 1386
2026
Q1
$152K Sell
115,549
-6,377
-5% -$11.4K ﹤0.01% 1326
2025
Q4
$228K Sell
121,926
-11,951
-9% -$23K ﹤0.01% 1217
2025
Q3
$171K Sell
133,877
-20,230
-13% -$27.4K ﹤0.01% 1255
2025
Q2
$191K Sell
154,107
-5,695
-4% -$6.58K ﹤0.01% 1120
2025
Q1
$189K Sell
159,802
-5,629
-3% -$8.64K ﹤0.01% 1054
2024
Q4
$303K Buy
165,431
+41,884
+34% +$81.8K ﹤0.01% 969
2024
Q3
$210K Buy
123,547
+122,554
+12,342% +$201K ﹤0.01% 1050
2024
Q2
$1K Sell
993
-581
-37% -$1.17K ﹤0.01% 694
2024
Q1
$6K Buy
1,574
+563
+56% +$3.3K ﹤0.01% 668
2023
Q4
$10K Sell
1,011
-368
-27% -$3.01K ﹤0.01% 585
2023
Q3
$12K Buy
1,379
+253
+22% +$2.89K ﹤0.01% 566
2023
Q2
$15K Buy
1,126
+66
+6% +$802 ﹤0.01% 547
2023
Q1
$12K Buy
1,060
+132
+14% +$1.31K ﹤0.01% 565
2022
Q4
$8K Buy
928
+188
+25% +$1.62K ﹤0.01% 604
2022
Q3
$4K Sell
740
-17
-2% -$98 ﹤0.01% 627
2022
Q2
$3K Sell
757
-5
-0.7% -$30 ﹤0.01% 649
2022
Q1
$7K Buy
762
+14
+2% +$161 ﹤0.01% 635
2021
Q4
$15K Buy
+748
New +$18.1K ﹤0.01% 546

Other funds holding PACB

Benjamin Edwards's PACB Position: Q3 2026 in Review

Benjamin Edwards reduced its Pacific Biosciences (PACB) stake by 3.7% in Q3 2026, selling an estimated $5.68K and leaving 103,695 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Benjamin Edwards first reported a position in PACB in Q4 2021 and has held it in 20 quarters since. The position peaked at $303K in Q4 2024. 146 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Benjamin Edwards held 103,695 shares of Pacific Biosciences worth $246K as of Q3 2026.
  • Benjamin Edwards sold 4,020 Pacific Biosciences shares in Q3 2026, an estimated $5.68K.
  • Pacific Biosciences made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1333 holding.
  • Benjamin Edwards first reported a position in Pacific Biosciences in Q4 2021 and has held it in 20 quarters since.
  • Benjamin Edwards's Pacific Biosciences position peaked at $303K in Q4 2024.
  • 146 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.